Skip to main content

Statin Use Increased From 1999-2000 to 2013-2014, Then Plateaued

Medically reviewed by Melisa Puckey, BPharm. Last updated on Dec 5, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 4, 2023 -- Overall statin use for primary prevention increased since 1999 to 2000 but has plateaued since 2013 to 2014, according to a research letter published online Dec. 5 in the Annals of Internal Medicine.

Casey J. Kim, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues describe trends in statin use for primary prevention across indication categories and atherosclerotic cardiovascular disease (ASCVD) risk scores in a repeated cross-sectional study using data from the National Health and Nutrition Examination Survey from 1999 to 2018. Data were included for 21,961 adults, representing a weighted population varying from 173.9 million in 1999 to 2000 to 215.5 million in 2017 to 2018.

The researchers found that 35.6 percent of the population had an indication for statin use for primary prevention. There was an increase from 11.6 to 33.6 percent observed in the proportion of guideline-eligible adults who reported receiving statins from 1999-2000 to 2013-2014. No change in statin use was seen between 2013 to 2014 and 2017 to 2018. For adults newly recommended statins by the 2013 American College of Cardiology/American Heart Association guidelines, no change was seen in the proportion using statins between 2013 to 2014 and 2017 to 2018. For adults with diabetes and adults with ASCVD risk greater than 20 percent, increases were seen in the proportion using statins between 1999 to 2000 and 2013 to 2014 (31.1 and 23.1 percentage points, respectively), but not between 2013 to 2014 and 2017 to 2018.

"Novel efforts, informed by implementation science and targeting patients with the greatest risk, are urgently needed," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

Apple Cider Vinegar Beneficial for Overweight, Obese Individuals

WEDNESDAY, March 13, 2024 -- For overweight and obese individuals, apple cider vinegar (ACV) consumption is associated with a significant reduction in anthropometric variables, as...

Dyslipidemia Raising Risk for CVD Among Young American Indians

TUESDAY, March 12, 2024 -- Dyslipidemia is associated with subclinical and clinical cardiovascular disease (CVD) among young American Indians, according to a study published...

2015 to 2021 Saw Marked Rise in PCSK9 Inhibitor Utilization

TUESDAY, March 5, 2024 -- Barriers for proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) use persist for cholesterol management, according to a research letter...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.